Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice

Vaccine

Volumn 15, Issue 5, 1997, Pages 547-552

  Kochel, Tadeusz ^a   Wu, Shuenn Jue ^a   Raviprakash, Kanakatte ^a   Hobart, Peter ^b   Hoffman, Stephen ^a   Porter, Kevin ^a   Hayes, Curtis ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b VICAL INC   (United States)

Author keywords

dengue 2 virus; neutralizing antibodies; nucleic acid vaccine

Indexed keywords

DENGUE VACCINE; NEUTRALIZING ANTIBODY; NUCLEIC ACID; PLASMID DNA; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS PLAQUE;

EID: 0030928465     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00215-6     Document Type: Article

References (37)

1. Russel, P. and Nisalak, A. Dengue virus identification by the plaque reduction neutralization test. J. Immunol. 1967, 99, 291-296
2. Chambers, T.J., Hahn, C.S., Galler, R. and Rice, C.M. Flavivirus genome organization, expression, and replication. A. Rev. Microbiol. 1990, 44, 649-688
3. Halstead, S.B. Selective primary health care: strategies for control of disease in the developing world. XI. Dengue. Rev. Infect. Dis. 1984, 6, 251-264
4. Halstead, S.B. Pathogenesis of dengue: challenges to molecular biology. Science 1988, 239, 476-481
5. Schlesinger, R.W. Dengue Viruses. Springer-Verlag Wien, New York, 1977
6. Eckels, K.H., Dubois, D.R. and Summers, P.L. et al. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection. Am. J. Trop. Mod. Hyg. 1994, 50, 472-478
7. Deubel, V., Kinney, R. and Esposito, J. et al. Dengue-2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J. Gen. Virol. 1988, 69, 1921-1929
8. Edelman, R., Tacket, C.O. and Wasserman, S.S. et al. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J. Infect. Dis. 1994, 170, 1448-1455
9. McKee, K.T.Jr, Bancroft, W.H., Eckels, K.H., Redfield, R.R., Summers, P.L. and Russell, P.K. Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am. J. Trop. Med. Hyg. 1987, 36, 435-442
10. Bhamarapravati, N., Yoksan, S., Chayaniyayothin, T., Angsubphakorn, S. and Bunyaratvej, A. Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bull. Wld Hlth Organ. 1987, 65, 189-195
11. Sedegah, M., Hedstrom, R., Hobart, P. and Huffman, S. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl Acad. Sci. USA 1994, 91, 9866-9870
12. Wang, B., Boyer, J. and Srikantan, V. et al. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and non-human primates. DNA Cell Biol. 1993, 12, 799-805
13. Ulmer, J., Donnely, J. and Parker, S. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749
14. Major, M., Vitvitski, L. and Mink, M. et al. DNA-based immunization with chimeric vector for the induction of immune responses against hepatitis C virus nucleocapsid. J. Virol. 1995, 69, 5798-5805
15. Rhodes, G., Dwarki, V. and Abai, A. et al. Injection of expression vectors containing viral genes induces cellular, humoral, and protective immunity. Vaccines 1993, 93, 137-141
16. Sambrook, J., Fritsch, E. and Manniatis, T. Molecular Cloning a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989
17. Megret, R, Hugnot, J.P. and Falconar, A. et al. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 1992, 187, 480-491
18. Henchal, E., Gentry, M., McCown, J. and Brandt, W. Dengue virus specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 1982, 31, 830-836
19. Raz, E., Carson, D.A. and Parker, S.E. et al. Intradermal gene immunization: the possible role of DMA uptake in the induction of cellular immunity to viruses. Proc. Natl Acad. Sci. USA 1994, 91, 9519-9523
20. Cole, G.A., Charles, J. and Wisseman, L. Pathogenesis of type 1 dengue virus infection in suckling, weanling and adult mice. Am. J. Epidemiol. 1969, 89, 669-680
21. Ansari, M., Shope, R. and Malik, S. Evaluation of vero cell lysate antigen for the ELISA of flaviviruses. J. Clin. Lab. 1993, 7, 230-237
22. Eckels, K., Brandt, W., Harrison, V., McCown, J. and Russel, P. Isolation of temperature sensitive dengue 2 virus under conditions suitable for vaccine development. Infect. Immun. 1976, 14, 1221-1227
23. Gruenberg, A., Woo, W.S., Biedrzycka, A. and Wright, P.J. Partial nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue virus type 2, new guinea C and PUO-218 strains. J. Gen. Virol. 1988, 69, 1391-1398
24. Allison, S.L., Stadler, K., Mandl, C.W., Kunz, C. and Heinz, F.X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 1995, 69, 5816-5820
25. Ulmer, J.B., Deck, R.R., DeWitt, C.M., Friedman, A., Donnelly, J.J. and Liu, M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 1994, 12, 1541-1544
26. Coney, L., Wang, B. and Ugen, K.E. et al. Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 1994, 12, 1545-1550
27. Davis, H.L., Michel, M.-L, Mancini, M., Schleef, M. and Whalen, R.G. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 1994, 12, 1503-1509
28. Webster, R.G., Fynan, E.F., Santoro, J.C. and Robinson, H. Protection of ferrets against influenza challenge with a DMA vaccine to the haemagglutinin. Vaccine 1994, 12, 1495-1500
29. Yankauckas, M.A., Morrow, J.E. and Parker, S.E. er al. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid dna containing NP gene. DNA Cell Biol. 1993, 12, 771-776
30. Bray, M., Zhao, B.T., Markoff, L, Eckels, K.H., Chanock, P.M. and Lai, C.J. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis. J. Virol. 1989, 63, 2853-2856
31. Delenda, C., Frenkiel, M.P. and Deubel, V. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells. Arch. Virol. 1994, 139, 197-207
32. Feighny, R., Burrous, J. and Putnak, R. Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge. Am. J. Trop. Med. Hyg. 1994, 50, 322-328
33. Fonseca, B.A., Pincus, S., Shope, R.E., Paoletti, E. and Mason, P.W. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice (published erratum appears in Vaccine 1994, 12, 480). Vaccine 1994, 12, 279-285
34. Delenda, C., Frenkiel, M. and Deubel, V. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells. Arch. Virol. 1994, 139, 197-207
35. Konishi, E., Pincus, S., Paoletti, E., Shope, R. and Mason, P. Avipos virus-vectored Japanese Encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 1994, 12, 633-638
36. Pincus, S., Mason, P. and Konishi, E. et al. Recombinant vaccinia virus producing the preM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 1992, 187, 290-297
37. Venugopal, K., Jiang, W. and Gould, E. Immunity to St. Louis encephalitis virus by sequential immunization with recombinant vaccinia and baculovirus derived PrM/E proteins. Vaccine 1995, 13, 1000-1005